Search

Your search keyword '"Papi, Laura"' showing total 322 results

Search Constraints

Start Over You searched for: Author "Papi, Laura" Remove constraint Author: "Papi, Laura" Search Limiters Full Text Remove constraint Search Limiters: Full Text
322 results on '"Papi, Laura"'

Search Results

1. Ovarian cancer pathology characteristics as predictors of variant pathogenicity in BRCA1 and BRCA2

3. A novel CDKN2A in-frame deletion associated with pancreatic cancer-melanoma syndrome

4. ERN GENTURIS clinical practice guidelines for the diagnosis, treatment, management and surveillance of people with schwannomatosis

5. Polygenic risk modeling for prediction of epithelial ovarian cancer risk

6. A Clinical Workflow for Cost-Saving High-Rate Diagnosis of Genetic Kidney Diseases

7. When to test fetuses for RASopathies? Proposition from a systematic analysis of 352 multicenter cases and a postnatal cohort

8. Polygenic risk scores and breast and epithelial ovarian cancer risks for carriers of BRCA1 and BRCA2 pathogenic variants

9. An original phylogenetic approach identified mitochondrial haplogroup T1a1 as inversely associated with breast cancer risk in BRCA2 mutation carriers

10. Expanding the mutational spectrum of LZTR1 in schwannomatosis

11. Identification of six new susceptibility loci for invasive epithelial ovarian cancer.

12. Candidate Genetic Modifiers for Breast and Ovarian Cancer Risk in BRCA1 and BRCA2 Mutation Carriers

13. Correction: Polygenic risk modeling for prediction of epithelial ovarian cancer risk

14. Associations of common breast cancer susceptibility alleles with risk of breast cancer subtypes in BRCA1 and BRCA2 mutation carriers.

15. Refined histopathological predictors of BRCA1 and BRCA2 mutation status: a large-scale analysis of breast cancer characteristics from the BCAC, CIMBA, and ENIGMA consortia.

16. Refined histopathological predictors of BRCA1 and BRCA2mutation status: a large-scale analysis of breast cancer characteristics from the BCAC, CIMBA, and ENIGMA consortia

17. DNA glycosylases involved in base excision repair may be associated with cancer risk in BRCA1 and BRCA2 mutation carriers.

18. Common breast cancer susceptibility alleles are associated with tumor subtypes in BRCA1 and BRCA2 mutation carriers: results from the Consortium of Investigators of Modifiers of BRCA1/2.

19. Meta-analysis identifies 29 additional ulcerative colitis risk loci, increasing the number of confirmed associations to 47

21. Central, Eastern, and Southeastern European Countries' Convergence: A Look at the Past and Considerations for the Future

22. Ovarian cancer pathology characteristics as predictors of variant pathogenicity in BRCA1 and BRCA2.

23. Essays on optimal government policy

24. Ovarian cancer pathology characteristics as predictors of variant pathogenicity in BRCA1 and BRCA2

25. Updated diagnostic criteria and nomenclature for neurofibromatosis type 2 and schwannomatosis: An international consensus recommendation

26. Updated diagnostic criteria and nomenclature for neurofibromatosis type 2 and schwannomatosis:An international consensus recommendation

27. FANCM c.5791C>T nonsense mutation (rs144567652) induces exon skipping, affects DNA repair activity and is a familial breast cancer risk factor

28. Revised diagnostic criteria for neurofibromatosis type 1 and Legius syndrome: an international consensus recommendation

29. Characterization of the cancer spectrum in men with germline BRCA1 and BRCA2 pathogenic variants

30. Genome-wide association study identifies 32 novel breast cancer susceptibility loci from overall and subtype-specific analyses

31. The Spectrum of FANCM Protein Truncating Variants in European Breast Cancer Cases

32. Characterization of the Cancer Spectrum in Men with Germline BRCA1 and BRCA2 Pathogenic Variants:Results from the Consortium of Investigators of Modifiers of BRCA1/2 (CIMBA)

34. Genetic Variation at 9p22.2 and Ovarian Cancer Risk for BRCA1 and BRCA2 Mutation Carriers

35. EPCO-04. GENOMIC AND EPIGENOMIC HALLMARKS OF SCHWANNOMATOSIS SCHWANNOMAS

39. Large scale multifactorial likelihood quantitative analysis of BRCA1 and BRCA2 variants: An ENIGMA resource to support clinical variant classification

40. Male breast cancer in BRCA1 and BRCA2 mutation carriers: pathology data from the Consortium of Investigators of Modifiers of BRCA1/2

41. Mutational spectrum in a worldwide study of 29,700 families with BRCA1 or BRCA2 mutations

42. Mutational spectrum in a worldwide study of 29,700 families with BRCA1 or BRCA2 mutations

43. Evaluation of polygenic risk scores for breast and ovarian cancer risk prediction in BRCA1 and BRCA2 mutation carriers

44. Identification of ten variants associated with risk of estrogen-receptor-negative breast cancer

45. Identification of 12 new susceptibility loci for different histotypes of epithelial ovarian cancer

48. Identification of ten variants associated with risk of estrogen-receptor-negative breast cancer.

49. Identification of 12 new susceptibility loci for different histotypes of epithelial ovarian cancer.

50. Association of breast cancer risk in BRCA1 and BRCA2 mutation carriers with genetic variants showing differential allelic expression

Catalog

Books, media, physical & digital resources